Výsledky vyhledávání - "Enrico, Gotti"

ANMCO position paper: guide to the appropriate use of the wearable cardioverter defibrillator in clinical practice for patients at high transient risk of sudden cardiac death

Autor: Giancarlo Casolo, Michele Massimo Gulizia, Daniela Aschieri, Alessandra Chinaglia, Marco Corda, Daniele Nassiacos, Salvatore Ivan Caico, Cristina Chimenti, Marzia Giaccardi, Enrico Gotti, Stefano Maffé, Roberta Magnano, Gianluca Solarino, Domenico Gabrielli, Fabrizio Oliva, Furio Colivicchi

Publikováno v: European Heart Journal Supplements. 25:D294-D311

Extended risk stratification and optimal management of patients with a permanently increased risk of sudden cardiac death (SCD) are becoming increasingly important. There are several clinical conditions where the risk of arrhythmic death is present a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ca34c8ac32622265f542377e682455e5
https://doi.org/10.1093/eurheartjsupp/suad101

Zobrazit plný text záznamu

Akademický článek

Phenotyping Green and Roasted Beans of Nicaraguan Coffea Arabica Varieties Processed with Different Post-Harvest Practices

Autor: Gaia Meoni, Claudio Luchinat, Enrico Gotti, Alejandro Cadena, Leonardo Tenori

Publikováno v: Applied Sciences, Vol 11, Iss 24, p 11779 (2021)

Metabolomic tecniques have already been used to characterize two of the most common coffee species, C. arabica and C. canephora, but no studies have focused on the characterization of green and roasted coffee varieties of a certain species. We aim to

Externí odkaz: https://doaj.org/article/91f9bb38c7da4403bb1ec28f30c4033e

Zobrazit plný text záznamu

Role of cardiac magnetic resonance in stratifying the prognosis of patients with pulmonary arterial hypertension

Autor: A Albini, Enrico Gotti, F Pasca, D Guarino, Alessandra Manes, Massimiliano Palazzini, N Galie, A De Lorenzis, A Rinaldi, M Orzalkiewicz, Elisa Zuffa, Fabio Dardi, E Monti

Publikováno v: European Heart Journal. 42

Background Pulmonary arterial hypertension (PAH) is a rare disease characterized by a complex remodeling of heart structures. Cardiac magnetic resonance (CMR) is the gold standard for a non-invasive evaluation of right ventricle (RV) volumes and mass

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6990e92602abcbf9694711104387dec5
https://doi.org/10.1093/eurheartj/ehab724.1947

Zobrazit plný text záznamu

[Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension: 5 years of experience in Italy]

Autor: Francesco, Saia, Fabio, Dardi, Nevio, Taglieri, Mariangela, Rotunno, Alessandra, Manes, Daniele, Guarino, Elisa, Zuffa, Alessandro, De Lorenzis, Ilenia, Magnani, Alberto, Ballerini, Fabio, Niro, Sofia, Martin Suarez, Davide, Pacini, Enrico, Gotti, Nazzareno, Galiè, Massimiliano, Palazzini

Publikováno v: Giornale italiano di cardiologia (2006). 22(3 Suppl 1)

Balloon pulmonary angioplasty (BPA) represents a therapeutic option for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH) in patients who are not eligible for surgical pulmonary endarterectomy (PEA) or with persistent/recurrent s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6768c84eda21198c48e33665ef855a71
https://pubmed.ncbi.nlm.nih.gov/33847317

Zobrazit plný text záznamu

Pulmonary hypertension due to left heart disease: analysis of survival according to the haemodynamic classification of the 2015 ESC/ERS guidelines and insights for future changes

Autor: A Rinaldi, Enrico Gotti, Nazzareno Galiè, A Albini, Alessandra Manes, Massimiliano Palazzini, Maria Letizia Bacchi Reggiani, Fabio Dardi, E Monti

Publikováno v: European Journal of Heart Failure. 20:248-255

Aims Pulmonary hypertension (PH) is a relevant complication of left heart disease (LHD). The 2015 ESC/ERS PH guidelines report two different haemodynamic subsets of PH due to LHD (PH-LHD) based on levels of pulmonary vascular resistance (PVR) and dia

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e113870ba4e4f90c5ccd5ef5e0a4ca8c
https://doi.org/10.1002/ejhf.860

Zobrazit plný text záznamu

A new CT-score as index of hemodynamic changes in patients with chronic thromboembolic pulmonary hypertension

Autor: Maria Letizia Bacchi Reggiani, Massimiliano Palazzini, Maria Barbara Leone, Nazzareno Galiè, Maurizio Zompatori, Sofia Martin Suarez, Marica Giannotta, Enrico Gotti, Mariano Cefarelli

Publikováno v: La radiologia medica. 122:495-504

Our results confirm the diagnostic role of CTPA in evaluating patients with CTEPH and in addition open a new horizon in assessing hemodynamic changes in patients with CTEPH, only employing a CTPA, especially when RHC is contraindicated or not possibl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9954845560aaf3ebd6d2b39d010daf32
https://doi.org/10.1007/s11547-017-0750-x

Zobrazit plný text záznamu

P4688Additional role of unmodifiable risk factors in pulmonary arterial hypertension risk stratification according to current ESC/ERS guidelines

Autor: A Rinaldi, Elisa Zuffa, A De Lorenzis, N Galie, Mariangela Rotunno, D Guarino, F Pasca, Fabio Dardi, I Magnani, Massimiliano Palazzini, Alessandra Manes, Enrico Gotti

Publikováno v: European Heart Journal. 40

Background Current pulmonary hypertension (PH) guidelines stratify the risk of patients with pulmonary arterial hypertension (PAH) using a multiparametric approach. Anyway, the role of unmodifiable risk factors is not taken into account. Purpose The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::25db3c5c95301fe68eea88156ed6e5e3
https://doi.org/10.1093/eurheartj/ehz745.1069

Zobrazit plný text záznamu

Additional Role of Unmodifiable Risk Factors in Pulmonary Arterial Hypertension Risk Stratification According to Current ESC/ERS Guidelines

Autor: F Pasca, Mariangela Rotunno, Massimiliano Palazzini, Enrico Gotti, Elisa Zuffa, D Guarino, Andrea Rinaldi, Fabio Dardi, E Monti, Alessandro De Lorenzis, Nazzareno Galiè, I Magnani, Alessandra Manes

Publikováno v: B55. USE YOUR ILLUSION I: CLINICAL RESEARCH IN PAH.

Current pulmonary arterial hypertension (PAH) guidelines stratify PAH patients risk with a multiparametric approach. Anyway, the role of unmodifiable risk factors is not taken into account. We evaluate the role of unmodifiable risk factors (age, gend

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfc8a9b0a8c33921c27cc36dd7854ef0
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3650

Zobrazit plný text záznamu

Effect of Pulmonary Arterial Hypertension Specific Therapy in the Four Clinical Subgroups of Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Autor: Enrico Gotti, D Guarino, Mariangela Rotunno, F Pasca, Nazzareno Galiè, Alessandro De Lorenzis, I Magnani, Alessandra Manes, Massimiliano Palazzini, Elisa Zuffa, Andrea Cassani, Andrea Rinaldi, Fabio Dardi

Publikováno v: B55. USE YOUR ILLUSION I: CLINICAL RESEARCH IN PAH.

Pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) is very heterogeneous and there are few data on the effect of PAH-specific therapy except for patients with Eisenmenger's syndrome (ES) and PAH after defect correction

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f0c9b4ee37367cd4214c918f6d7d2d
https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3653

Zobrazit plný text záznamu

Effects of sildenafil as a bridge therapy for pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension

Autor: Shigefumi Fukui, Satoshi Yasuda, Davide Pacini, Sofia Martin Suarez, Norifumi Nakanishi, Takeshi Ogo, Nazzareno Galiè, Alessandra Manes, Enrico Gotti, Massimiliano Palazzini

Publikováno v: Pulmonary hypertension.

Background: It is reported that there is no benefit of pulmonary hypertensive medical therapy (PHT) in patients undergoing pulmonary endarterectomy (PEA), except improved total pulmonary resistance with epoprostenol (Kurt W et al. Circulation 2009).

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::614f2eb03d8dfaf3df216c6cb11d2ad1
https://doi.org/10.1183/13993003.congress-2018.pa3055

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání